Horizons Ventures

Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

Medal is a short-form gaming video clips platform used to share digital game clips and highlights with gamers. Its platform helps to capture the final seconds of gameplay utilizing completely different recording mechanisms that can be shared on the application that provide clips of live streams and that enable users to share their skills and get an enjoyable experience. The company was founded in 2015 and is headquartered in Naarden, North-Holland.

Holoclara is an immunotherapy company focused on developing treatments for autoimmune disorders using nematode-derived molecules. The company aims to provide relief to individuals suffering from these conditions by offering a range of services that include the delivery of therapeutics derived from worm species. These molecules are identified for their potent therapeutic properties and are being developed into safe, orally available treatments. Holoclara’s initiatives are designed to enable patients to lead healthier lives while addressing the challenges posed by autoimmune disorders.

Voyage Foods is focused on creating sustainable and scalable alternatives to popular food products that face challenges due to health, environmental, and social issues. The company utilizes natural, sustainable, and upcycled ingredients along with proprietary technology and food science to develop new food items that replicate the taste and appearance of traditional favorites. Their product offerings include Nut-Free Spreads, Cocoa-Free Chocolate, and Bean-Free Coffee, all designed to provide the same enjoyment without compromising individual health or environmental integrity. This innovative approach allows consumers to savor their favorite foods while contributing to a more responsible food system.

Fano Labs is an AI company headquartered in Hong Kong specialised in Speech Recognition and Natural Language Processing technologies. Focusing in a variety of languages, dialects and mixed languages; specially Cantonese and languages in Southeast Asia, our solutions help enterprises from various sectors with customer service, compliance and other lines of business. With the advanced AI technologies, Fano Labs provides a smart Customer Service and Speech Analytics System, for customers from various sectors, where they can greatly enhance their management capability and service quality, by accurately identifying potential compliance risks while detecting and analysing the sentiment of the customers. Also, it will allow enterprises to reduce costs and uncover potential sales opportunities by providing managers with valuable business intelligence which will lead to revenue increases.

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.

Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.

MioTech is an artificial intelligence platform that empowers investment managers to better serve their clients in a world of complex data. By integrating and analyzing data from all types of sources, MioTech streamlines the entire investment process, creating an ultimate data-driven investing experience. MioTech has offices in Shanghai and Hong Kong. MioTech is backed by Horizons Ventures, ZhenFund, and prestigious individual investors around the world.

CellVoyant Technologies Limited, founded in 2021, focuses on advancing biotechnology through an AI-first approach to stem cell-based therapies aimed at treating chronic diseases. The company employs AI-driven live cell imaging to predict and optimize stem cell differentiation, allowing for the scalable and precise manufacturing of various human cells and tissues. This innovative technology is rooted in research from the Carazo Salas lab at the University of Bristol, merging expertise in cell biology, computer vision, engineering, and machine learning. With a commitment to translating cutting-edge science into practical healthcare solutions, CellVoyant addresses significant challenges in medicine. The company, led by Founder and CEO Rafael Carazo, has garnered support from a network of investors experienced in AI and biotechnology. Currently generating $2.5 million in annual revenue, CellVoyant is positioned to make a substantial impact in the biotechnology sector through its transformative therapies.

Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.

KimiaTherapeutics is a drug discovery business that uses high throughput precision chemistry in conjunction with genome editing and machine learning to uncover druggable sites at crucial nodes of intervention in human disease.

Evolv AI is a developer of an artificial intelligence-driven optimization and personalization platform that aims to enhance digital experiences for customers. The company focuses on enabling digital leaders and content creators to engage customers effectively across various digital channels. Its proprietary platform employs a unique methodology to automatically discover and personalize user journeys by adapting to live user behavior. By defining experimentation strategies and generating a continuous stream of innovative ideas, Evolv AI helps organizations progressively improve their digital optimization efforts. This allows businesses to learn from each user interaction and refine their approaches, ultimately driving better customer engagement and conversion rates.

erthos is a producer of biodegradable packaging materials intended to replace traditional polystyrene and polypropylene inputs.

BioLoomics, Inc. is a biotechnology company based in Boulder, Colorado, founded in 2019. It specializes in drug screening services that analyze drug action and toxicity through the use of biosensors and advanced imaging technology. BioLoomics develops tools aimed at enhancing drug discovery by employing directed evolution to create antibodies with programmable spatial fate in target cells. The company's technology facilitates high-throughput multiplexed profiling of biochemical events in live mammalian cells, allowing for the screening of chemical libraries and bioactive nanoparticles. This innovative approach enables clients to observe unique cellular responses and sustainably induce hormone secretion, ultimately improving the success rates and reducing costs associated with drug development.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

ALVA Intelligent electric Vehicle's lineup is assembled in Indonesia and features incredible motor efficiency and performance, as well as integrated intelligence to provide our riders with greater security, personalization, and control.

Chemify is a developer of a chemical digitization platform that integrates automated synthetic hardware with a unique chemical programming language. This platform allows for the on-demand conversion of digital code into molecules, facilitating drug and materials discovery as well as chemical synthesis. Chemify's system is designed to be modular, universal, scalable, and teachable, making it suitable for various applications in chemical and material research. The software incorporates natural language processing to translate synthetic procedures and features a comprehensive ontology, which aids users in creating chemical processes while providing insights into reaction conditions and identifying potential issues. This capability enables scientists to access detailed real-time telemetry of chemical reactions, enhancing efficiency and accuracy in their work.

Cortical Labs is a biological computing startup focused on integrating living neurons into computer chips to transform conventional computing. Their innovative technology, known as biOS, allows these biological chips to transmit data through electrical signals generated by the neurons. This process enables the neurons to adapt based on the perceived impact of their actions within the system, resulting in a self-programming and highly flexible computing solution. The chips are designed to provide fluid intelligence and enhanced power efficiency, making them suitable for various applications in digital environments, robotics, science, and personal care. By leveraging the capabilities of human neurons, Cortical Labs aims to create advanced autonomous systems that can significantly advance next-generation computing.

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities faster and with a lower cost of goods than any traditional production method.

Matchday is a gaming platform tailored for football enthusiasts, enabling users to collect and trade digital cards within a marketplace. The platform merges video games, sports, and Web3 technology to create an engaging ecosystem for casual football games. Users have genuine ownership of the cards and digital items they acquire, allowing them to build their dream teams and enjoy seamless gameplay.

Doctorly GmbH is a health tech company based in Berlin, Germany, that specializes in a cloud-based practice management platform for healthcare professionals. Founded in 2017, Doctorly offers a comprehensive software-as-a-service solution designed to enhance efficiency and reduce costs for doctors. The platform includes features such as digital booking, video conferencing, electronic health records, and patient health analysis. Additionally, it facilitates seamless integration with other tools and workflows in the healthcare sector, allowing for improved connectivity between doctors and patients. Doctorly aims to drive meaningful change within the healthcare industry by providing innovative digital solutions that streamline practice management.

Loam Bio is a developer of microbial carbon sequestration technology for soil carbon restoration. Crops can be inoculated with symbiotic microorganisms that live in a mutualistic relationship with crops and build organic carbon in the soil, allowing farmers to improve the host plant's fertility and disease resistance while also assisting the soil around the plant's roots to store carbon more effectively, resulting in proper quality soil for future planting. Loam Bio was established in 2019 by Guy Hudson.

Asimov, Inc. is a biotechnology company that specializes in the design and development of genetically engineered therapeutics. Established in 2017 and based in Cambridge, Massachusetts, Asimov focuses on creating tools for programming living cells to enhance the design and manufacturing processes of biologics and gene therapies. The company's platform integrates synthetic biology, computer-aided design, and machine learning, allowing for the engineering of genetic circuits. Asimov's multidisciplinary team employs machine-learning algorithms that connect large-scale datasets with biological models, facilitating advancements in molecular manufacturing and therapeutic applications. The company is dedicated to optimizing the production of protein biologics, viral vectors, and cell and gene therapies.

Syzygy Plasmonics, Inc. is a Houston-based company that designs, develops, and manufactures photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors capable of generating fuel cell quality hydrogen from ammonia, making them suitable for small-to-medium-scale applications and hydrogen refueling stations for fuel cell vehicles. Unlike conventional chemical reactors, Syzygy's technology operates using light as an energy source and at temperatures over 1,000°F lower, which significantly reduces maintenance costs and allows for rapid production start-stop capabilities. This innovative approach not only enhances efficiency but also supports the decarbonization of hard-to-abate industries by enabling the use of renewable electricity and minimizing reliance on fossil fuels.

Detect they build tools that empower people to understand their health.

Juvena Therapeutics, Inc. is a biopharmaceutical company based in San Mateo, California, founded in 2017. The company specializes in developing protein-based therapeutics aimed at promoting tissue rejuvenation and addressing age-related diseases in the elderly. Its innovative platform focuses on discovering novel therapeutics that restore cellular functions, targeting conditions such as sarcopenia, wound healing, and neural regeneration. By decoding secreted proteins, Juvena Therapeutics aims to provide solutions for chronic and rare diseases, enhancing the quality of life for aging populations.

Nourish Ingredients is a food tech company based in Canberra, Australia, founded in 2019. The company specializes in creating animal fat molecules through proprietary precision fermentation, allowing for the mass production of these fats without involving animals. This innovative approach enables the development of alternative proteins that replicate the flavor, smell, and cooking experience of traditional animal fats. By providing these potent fat molecules, Nourish Ingredients aims to enhance the taste and quality of plant-based products, catering to consumers seeking delicious and authentic alternatives to meat.

Kneron, Inc. is a company that designs and develops integrated software and hardware solutions for artificial intelligence applications, focusing on enabling AI functionality at the edge. Founded in 2015 and headquartered in San Diego, California, Kneron has additional offices in Taipei City, Zhuhai City, and Shenzhen City, China. The company's offerings include neural processing units (NPUs) tailored for smart homes, smart surveillance, smartphones, and wearable devices. Kneron also provides visual recognition software capable of on-device recognition of human faces, bodies, gestures, objects, and scenes. Their products support a range of applications, from robots and drones to Internet of Things (IoT) devices, ensuring real-time recognition and analysis without relying on cloud connections.

SaNOtize is a biotechnology company based in Vancouver, British Columbia, specializing in a Nitric Oxide Releasing Solution platform technology aimed at treating upper respiratory and dermal infections. Founded in 2017 by Gilly Regev and Chris Miller, the company focuses on developing non-antibiotic antimicrobial solutions to address a wide range of microbial infections, including those caused by drug-resistant pathogens. SaNOtize's technology targets various indications such as strep throat, athlete's foot, infected wounds, diabetic foot ulcers, sinusitis, and common cold and flu symptoms. By providing effective treatment options against bacteria, viruses, and fungi, SaNOtize aims to enhance the medical industry's ability to manage infectious diseases.

Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, the company focuses on discovering and developing therapies for metabolic diseases, including obesity and diabetes. Carmot employs a proprietary drug discovery approach known as Chemotype Evolution, which enables the exploration of novel chemical and biological frontiers. The company is advancing a portfolio of clinical-stage drug candidates, including CT-388, a once-weekly injectable dual GLP-1/GIP receptor agonist; CT-996, a once-daily oral GLP-1 receptor agonist; and CT-868, a once-daily injectable dual GLP-1/GIP receptor agonist for treating type 1 diabetes in patients with overweight or obesity. These innovative therapies aim to enhance glucose clearance and promote weight loss, addressing the fundamental causes of metabolic diseases.

Normative.io is a software company that specializes in assessing the social and environmental impact of companies by analyzing their purchases. Utilizing artificial intelligence and the world's largest sustainability research database, Normative's platform provides an emission accounting engine that helps organizations calculate their total carbon dioxide emissions. The software also offers visual analytics and generates comprehensive sustainability reports, processing both internal and external data to automate carbon reporting. By making the social and environmental costs of purchases transparent, Normative aims to facilitate progress toward achieving the Sustainable Development Goals and assist businesses in reducing their environmental footprint.

Spiderwort is a company focused on developing innovative biomaterials for regenerative medicine, aiming to repair and regenerate human tissues. Founded in 2015 and based in Ottawa, Ontario, the company utilizes plant-derived cellulose to create various scaffold architectures, including powders, gels, membranes, and pastes. Currently in the pre-clinical stage, Spiderwort's novel biomaterials have shown promising results in terms of biocompatibility and their ability to induce angiogenesis, the generation of new blood vessels within the scaffolds. This approach seeks to advance applications in the healthcare industry, particularly for spinal cord injury repair and soft tissue regeneration, by utilizing plant-based materials rather than traditional synthetic substances.

Wefox is an insurtech platform that connects insurance companies, brokers, businesses, and customers to facilitate access to digital insurance solutions. Operating as a digital insurance company, Wefox sells its products through intermediaries rather than directly to consumers, which broadens its market reach. The platform provides a variety of services, including policy management, claims settlement, and quotations for multiple types of insurance, such as health, liability, and disability. By offering a comprehensive suite of tools, Wefox aims to deliver personalized and suitable coverage options to its users, enhancing the overall insurance experience.

Keel Labs is a biomaterials company focused on producing sustainable materials derived from renewable resources, specifically seaweed. The company addresses the ecological damage associated with the fashion industry by developing a platform for creating durable and rapidly degradable yarns from kelp. This innovative approach integrates scientific research and design with waste reduction in textile production, offering a viable alternative to conventional textiles for the footwear and apparel industries. By utilizing kelp, Keel Labs provides a functional and environmentally friendly resource that aims to mitigate the negative impacts of traditional material sourcing.

Atomo Coffee Inc, founded in 2019 and headquartered in Seattle, Washington, specializes in the production of molecular coffee. The company has developed a unique process that reverse-engineers the coffee bean, allowing it to create a smooth cup of coffee using naturally derived ingredients. This innovative approach not only enhances the flavor profile but also offers a more sustainable alternative to traditional coffee production methods.

Manifold Bio is a biotechnology company that features a platform that enables multiplexed quantitation of protein therapeutic designs, generating unprecedented data throughout the drug development process to unlock measurement-driven design. The company is building a protein barcoding platform to bring the power of multiplexed measurement to the development of protein therapeutics. It was founded in 2020 and headquartered in Boston, Massachusetts.

getquin is a comprehensive platform designed to assist individuals in tracking their net worth and managing their investment portfolios. It allows users to monitor and analyze a variety of assets in one centralized location, facilitating informed investment decisions. The platform also fosters interaction among a community of investors, enabling users to share insights and strategies. By providing tools for continuous oversight of investments, getquin aims to enhance the investment experience and promote better financial outcomes for its users.

Voyage Foods is focused on creating sustainable and scalable alternatives to popular food products that face challenges due to health, environmental, and social issues. The company utilizes natural, sustainable, and upcycled ingredients along with proprietary technology and food science to develop new food items that replicate the taste and appearance of traditional favorites. Their product offerings include Nut-Free Spreads, Cocoa-Free Chocolate, and Bean-Free Coffee, all designed to provide the same enjoyment without compromising individual health or environmental integrity. This innovative approach allows consumers to savor their favorite foods while contributing to a more responsible food system.

Kelonia Therapeutics is developing a new wave of genetic medicines using its next-generation vivo gene delivery platform. The company's cutting-edge in vivo gene delivery technology is simple and elegant, relying on a few potent lentiviral vector-like particles to precisely and efficiently deliver genetic cargo to the desired target tissue, and only that tissue, every time. To deliver genetic cargo only to the desired tissue, the lentiviral vector gene delivery platform employs a simple and elegant solution based on decades of research, development, and technical experience. Kelonia's mission is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.

Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

Micro Connect is a financial market platform that specializes in connecting global capital with China's micro and small businesses. The company focuses on enhancing liquidity in small business investments by providing professional investors with a new alternative to traditional impact investing. Micro Connect introduces Daily Revenue Obligations (DROs), an innovative asset class that allows investors to gain direct and diversified exposure to the daily cash flows of numerous retail establishments within China's dynamic consumer market. By facilitating access to capital for business owners, Micro Connect aims to create a more affordable financial ecosystem, while also offering structured product solutions and operating a licensed exchange.

Concerto Biosciences specializes in rebuilding microbial communities to enhance human health and environmental sustainability. The company has developed an ultra-high-throughput platform capable of measuring millions of microbial interactions, enabling the mapping of complex inter-species networks that dictate community behavior. This innovation allows Concerto to create "ensembles," which are specific combinations of microbes that collaboratively promote the recovery of damaged microbial ecosystems. By focusing on these microbial ensembles, Concerto aims to address critical global issues across various sectors, including agriculture, healthcare, and industry. The company's pioneering work positions it as a leader in the development of microbial solutions, fundamentally changing how humanity interacts with microbial life.

Deepcell, Inc. is a biotechnology company based in Mountain View, California, that specializes in providing advanced diagnostic solutions through its innovative microfluidic imaging platform. Founded in 2015, the company focuses on delivering non-invasive tests with diagnostic-level accuracy, enabling researchers and clinicians to gain insights at the single-cell level. Deepcell's technology employs artificial intelligence to analyze and classify cells based on their morphological features, isolating viable cells for various applications in translational research, diagnostic testing, and therapeutics. By utilizing ordinary blood samples, Deepcell enhances the understanding of genetic health without the need for invasive procedures, thereby improving the diagnosis and treatment of diseases.

Soul Machines Limited, founded in 2016 and headquartered in Auckland, New Zealand, specializes in the development of emotionally responsive avatars that enhance user experiences across various artificial intelligence platforms. The company offers a range of products, including the Digital DNA Studio, which allows users to create custom digital avatars for applications in customer care, marketing, education, and more. By utilizing its innovative Biological AI technology and patented Digital Brain™, Soul Machines aims to humanize AI, creating engaging and empathetic AI assistants that facilitate deeper interactions and personalized experiences. With additional offices in major cities worldwide, including San Francisco, New York, London, Tokyo, and Melbourne, Soul Machines is at the forefront of transforming customer engagement through ethical and responsive human-machine collaboration.

H2Pro, Ltd. is a renewable energy company based in Caesarea, Israel, founded in 2019. The company specializes in developing innovative water-splitting technology aimed at producing hydrogen fuel efficiently. Its proprietary method, known as E-TAC (Electrochemical–Thermally-Activated Chemical water splitting), effectively decouples the hydrogen and oxygen evolution reactions, allowing for the generation of hydrogen and oxygen in separate phases. This technology is designed to facilitate the widespread adoption of sustainable hydrogen fuel by providing an efficient, affordable, safe, and environmentally friendly means of hydrogen production.

Fertilis is a company that makes in vitro fertilization (IVF) less stressful and more successful for patients and clinicians.

MeMed Diagnostics Ltd. is a personalized diagnostics company founded in 2009 and based in Tirat Carmel, Israel. The company develops innovative diagnostic solutions aimed at improving patient care and reducing healthcare costs, particularly through the prevention of antibiotic misuse. MeMed's flagship products include MeMed BV, a test that differentiates between bacterial and viral infections, and the ImmunoDx platform, which utilizes proprietary biomarkers and algorithms to analyze the immune system's responses to pathogens. This technology addresses significant challenges in infectious disease diagnostics, providing rapid and actionable insights that enable healthcare providers to make informed decisions regarding antibiotic treatments. By accurately identifying infection sources, MeMed aims to combat the inappropriate prescription of antibiotics, which contributes to the emergence of resistant bacterial strains and incurs substantial costs to healthcare systems worldwide.

Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.

Kopi Kenangan is one of several grab-and-go coffee chains trying to capitalize on the rising trend and demand for grounded coffee beverages in a country which has the lowest coffee consumption per capita in the region, despite being the world’s fourth-largest coffee exporter.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

Wonder Dynamics develops and combines AI technology with storytelling. The media-tech startup developing an AI production tool that would allow indie filmmakers to deliver blockbuster-level VFX on a fraction of the budget. Tye Sheridan and Nikola Todorovic co-founded the company in Los Angeles, California.

Notpla Limited is a London-based company that specializes in sustainable packaging solutions aimed at reducing waste and environmental impact. Founded in 2014, the company manufactures a range of products made from materials derived from seaweed and plants, including biodegradable takeaway food containers, flexible films, and paper products. Notpla's offerings also feature coatings for cardboard takeaway boxes and edible films, all designed to be naturally biodegradable without the need for specialized facilities. The company, formerly known as Skipping Rocks Lab, rebranded in July 2019 to reflect its commitment to creating eco-friendly packaging alternatives that help combat plastic waste and promote a healthier planet.

Harrison.ai is a clinician-led healthcare AI company based in Barongarook, Victoria, Australia, founded in 2018. The company specializes in using deep learning technology to enhance the success rates of in vitro fertilization (IVF) for patients. By developing AI-enabled tools that seamlessly integrate into existing clinical workflows, Harrison.ai aims to empower healthcare providers and improve patient outcomes. Its proprietary IVY deep learning model analyzes comprehensive video feeds from embryo scopes, outperforming traditional AI tools that rely on still images. Harrison.ai combines deep learning expertise with clinical experience to address significant challenges in healthcare, focusing on the continuous innovation and commercialization of efficient and affordable healthcare products and services.

Q-CTRL is a pioneering company in the quantum technology sector, focused on addressing critical challenges related to hardware error and instability. By developing advanced quantum control infrastructure software, Q-CTRL supports research and development professionals as well as end users in quantum computing, facilitating the transition to practical quantum computers. The company's innovative "Software-defined" quantum sensors are tailored for applications in defence, intelligence, navigation, and earth observation. With a team of expert quantum-control engineers, Q-CTRL collaborates with leading universities, national laboratories, and industry partners worldwide. As a notable member of the IBM Quantum Startup network and various industry consortia, Q-CTRL is recognized for its contributions to the field and has received several prestigious awards, including those from the Modern Manufacturing Initiative and the Next Generation Technology Fund. The company has garnered attention in major publications and was ranked among the Top 10 Most Innovative Tech Companies in Australia, highlighting its role in shaping the future of quantum technology.

Fleet Space Technologies is an Australian space technology company specializing in a constellation of commercial micro-satellites. The company has developed the world's first 3D printed all-metal patch antenna for space, significantly enhancing the throughput of its spacecraft. Fleet Space aims to transform critical mineral discovery, space exploration, and defense by utilizing its satellite-enabled systems and seismic array technology. Their innovative approach facilitates low-cost satellite-based solutions for Industrial Internet of Things applications, enabling clients to effectively explore for critical minerals globally and connect various celestial bodies, including Earth, the Moon, and Mars.

Synthace Limited is a company focused on transforming the way biological experimentation is conducted across various sectors, including health, pharmaceuticals, food, energy, agri-science, and industrial biotechnology. Established in 2011 and headquartered in London, with an additional office in Cambridge, Massachusetts, Synthace offers a cloud-based platform called Antha. This platform enables life science research and development teams to streamline their experimental processes by allowing scientists to design, plan, and execute reproducible experiments without requiring coding skills. Antha facilitates the automation of laboratory experiments and the organization of experimental data, making it easier for researchers to run complex experiments that might have been previously deemed impractical. The company has also formed a strategic partnership with Microsoft to enhance its offerings.

Making life easier for the service industry. Better jobs, better hires, and the only community exclusively for the service industry in your city.

Loam Bio is a developer of microbial carbon sequestration technology for soil carbon restoration. Crops can be inoculated with symbiotic microorganisms that live in a mutualistic relationship with crops and build organic carbon in the soil, allowing farmers to improve the host plant's fertility and disease resistance while also assisting the soil around the plant's roots to store carbon more effectively, resulting in proper quality soil for future planting. Loam Bio was established in 2019 by Guy Hudson.

Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

Ajaib is a financial technology company based in Jakarta, Indonesia, that provides an online wealth management platform designed to democratize access to investment opportunities. Founded in 2019, Ajaib allows users to buy and sell stocks, exchange-traded funds (ETFs), and mutual funds through its user-friendly application. The platform is aimed at making investing accessible to all Indonesians, regardless of their financial background, by offering low minimum investment requirements and no account fees. Ajaib's mission is to provide safe, trusted, and affordable investment options, enabling individuals to save and grow their wealth effectively while minimizing risk.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.

Prospection is a prominent health insights company that specializes in healthcare data analytics, employing predictive analytics and machine learning to extract valuable insights from real-world healthcare data. Established in 2012 in Sydney, Prospection collaborates with government entities, pharmaceutical companies, and the medical community across a wide range of therapy programs, including immuno-oncology, diabetes, respiratory diseases, HIV, and hepatitis, operating in regions such as Australia, Japan, the Asia Pacific, the UK, and the USA. The company offers a software-as-a-service (SaaS) platform that transforms healthcare data into actionable insights, analyzing longitudinal patient data, geo-mapping, and medication utilization. This enables healthcare clients, including pharmaceutical manufacturers and research institutions, to enhance drug performance and improve patient outcomes through innovative data analytics solutions.

Owlstone Medical Ltd is a diagnostics company based in Cambridge, United Kingdom, specializing in non-invasive breath-based diagnostic tools aimed at the early detection of diseases, including cancer and respiratory conditions. The company develops a range of innovative products, including its Breath Biopsy platform, which utilizes advanced technology to identify volatile organic compounds in breath samples. Its offerings include FAIMS technology for medical applications, Lonestar for disease biomarker detection, and ReCIVA breath samplers for in vitro analysis. Owlstone Medical's technology has significant applications in various medical fields, such as lung cancer, bowel cancer, and gastrointestinal disorders. The company is also exploring the development of a portable hand-held device that promises high sensitivity and selectivity for chemical detection, with potential applications across multiple markets, including military and industrial sectors. Owlstone Medical aims to become a leader in non-invasive diagnostics, with ongoing collaborations and trials, including contracts with the UK National Health Service for lung cancer screening initiatives.

Alpaca is a developer-focused financial technology platform that provides an embedded brokerage infrastructure for accessing financial markets through modern application programming interfaces (APIs). The platform enables users to trade stocks and cryptocurrencies, offering real-time market data and tools for algorithmic trading. With its developer-friendly approach, Alpaca supports a wide range of applications and businesses worldwide, attracting tens of thousands of developers who utilize its services to create and enhance investing applications. The company has raised over $100 million in funding from prominent investors, reflecting its strong position in the financial technology landscape.

V2food is a plant-based meat startup based in Sydney, New South Wales, Australia, founded in 2019 by Nick Hazell. The company specializes in producing legume-based meat alternatives aimed at providing a nutritious and delicious option for individuals who enjoy the taste of meat but prefer not to consume animal products. V2food's offerings emphasize natural ingredients that are rich in protein, energy, fiber, and essential amino acids, promoting a sustainable approach to food consumption. The products are designed to minimize greenhouse gas emissions, land degradation, and biodiversity loss, making them an eco-friendly choice for consumers seeking to foster positive relationships with food while contributing to a more sustainable planet.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

Bad Robot, founded by filmmaker J.J. Abrams in 2001 and based in Santa Monica, is an entertainment company that focuses on storytelling across various mediums, including television, film, and interactive content. The company has produced acclaimed television series such as ALIAS, LOST, FRINGE, PERSON OF INTEREST, and WESTWORLD, along with feature films in popular franchises like STAR WARS, STAR TREK, and MISSION: IMPOSSIBLE. Bad Robot has also ventured into publishing, with its novel S. becoming a New York Times Best Seller. Additionally, Bad Robot Games emphasizes immersive storytelling through video games, collaborating with industry veterans and leveraging Hollywood talent to create expansive narratives. Overall, Bad Robot is dedicated to crafting engaging experiences that resonate with audiences across multiple platforms.

Modern Meadow, LLC is a biofabrication company based in Brooklyn, New York, founded in 2011. The company specializes in creating animal-free leather from living cells, utilizing its proprietary Bio-Alloy and Bio-Farm technology platforms. These innovations leverage tuned proteins to produce sustainable materials that eliminate the need for petrochemical and animal-derived inputs while maintaining high performance. Modern Meadow’s products are designed for seamless integration into existing infrastructures across various industries, including materials and beauty. The company emphasizes lab-to-brand traceability, ensuring that its offerings are fully transparent throughout the production process. By focusing on fermentation-based bio-collagen and lightweight materials, Modern Meadow aims to significantly reduce greenhouse gas emissions and promote sustainability without compromising quality or appearance.

Syzygy Plasmonics, Inc. is a Houston-based company that designs, develops, and manufactures photocatalytic reactor systems for industrial chemical reactions. Founded in 2017, the company focuses on creating reactors capable of generating fuel cell quality hydrogen from ammonia, making them suitable for small-to-medium-scale applications and hydrogen refueling stations for fuel cell vehicles. Unlike conventional chemical reactors, Syzygy's technology operates using light as an energy source and at temperatures over 1,000°F lower, which significantly reduces maintenance costs and allows for rapid production start-stop capabilities. This innovative approach not only enhances efficiency but also supports the decarbonization of hard-to-abate industries by enabling the use of renewable electricity and minimizing reliance on fossil fuels.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

Ajaib is a financial technology company based in Jakarta, Indonesia, that provides an online wealth management platform designed to democratize access to investment opportunities. Founded in 2019, Ajaib allows users to buy and sell stocks, exchange-traded funds (ETFs), and mutual funds through its user-friendly application. The platform is aimed at making investing accessible to all Indonesians, regardless of their financial background, by offering low minimum investment requirements and no account fees. Ajaib's mission is to provide safe, trusted, and affordable investment options, enabling individuals to save and grow their wealth effectively while minimizing risk.

Nourish Ingredients is a food tech company based in Canberra, Australia, founded in 2019. The company specializes in creating animal fat molecules through proprietary precision fermentation, allowing for the mass production of these fats without involving animals. This innovative approach enables the development of alternative proteins that replicate the flavor, smell, and cooking experience of traditional animal fats. By providing these potent fat molecules, Nourish Ingredients aims to enhance the taste and quality of plant-based products, catering to consumers seeking delicious and authentic alternatives to meat.

Keel Labs is a biomaterials company focused on producing sustainable materials derived from renewable resources, specifically seaweed. The company addresses the ecological damage associated with the fashion industry by developing a platform for creating durable and rapidly degradable yarns from kelp. This innovative approach integrates scientific research and design with waste reduction in textile production, offering a viable alternative to conventional textiles for the footwear and apparel industries. By utilizing kelp, Keel Labs provides a functional and environmentally friendly resource that aims to mitigate the negative impacts of traditional material sourcing.

Voyage Foods is focused on creating sustainable and scalable alternatives to popular food products that face challenges due to health, environmental, and social issues. The company utilizes natural, sustainable, and upcycled ingredients along with proprietary technology and food science to develop new food items that replicate the taste and appearance of traditional favorites. Their product offerings include Nut-Free Spreads, Cocoa-Free Chocolate, and Bean-Free Coffee, all designed to provide the same enjoyment without compromising individual health or environmental integrity. This innovative approach allows consumers to savor their favorite foods while contributing to a more responsible food system.

ALE, founded in 2011, specializes in creating innovative space entertainment experiences, notably through its pioneering man-made meteor shower technology. The company employs microsatellites to release particles that produce visual meteor events during atmospheric re-entry, blending meteor science with entertainment. ALE aims to engage the public’s curiosity about space and science while also serving a scientific purpose by collecting valuable data from the mesosphere. By connecting science with society, ALE seeks to stimulate interest in space exploration and enhance understanding of atmospheric phenomena. The company also strives to foster a community of scientists and decision-makers committed to advancing research and developing sustainable solutions for Earth. Through its unique approach, ALE positions itself at the intersection of entertainment, scientific inquiry, and environmental stewardship.

Otter.ai, Inc. is a technology company that specializes in artificial intelligence applications for managing voice conversations. Founded in 2016 and headquartered in Los Altos, California, the company offers a mobile and web app called Otter, which allows users to store, search, and share notes from meetings, interviews, and lectures. The platform utilizes advanced speech recognition technology to create real-time transcripts, making the information easily accessible and actionable. Otter's features include speaker separation, speaker identification, and keyword extraction, catering to business professionals, journalists, and students alike. By facilitating collaboration and enabling users to edit, organize, and export their voice notes, Otter.ai enhances productivity and communication in various settings, including education and team environments.

Kuato Studios is an educational games developer based in London, dedicated to enhancing children's learning experiences through innovative video games. The studio combines expertise from renowned game developers, artificial intelligence specialists, and award-winning education professionals to create engaging and effective educational content. By focusing on narrative learning play, Kuato aims to motivate children and facilitate personal learning experiences that appeal to their interests. The company leverages its adaptive learning platform, KAI, to deliver personalized educational interactions while maintaining high production values. This unique blend of creativity and educational insight positions Kuato at the forefront of redefining the standards for educational gaming.

Ajaib is a financial technology company based in Jakarta, Indonesia, that provides an online wealth management platform designed to democratize access to investment opportunities. Founded in 2019, Ajaib allows users to buy and sell stocks, exchange-traded funds (ETFs), and mutual funds through its user-friendly application. The platform is aimed at making investing accessible to all Indonesians, regardless of their financial background, by offering low minimum investment requirements and no account fees. Ajaib's mission is to provide safe, trusted, and affordable investment options, enabling individuals to save and grow their wealth effectively while minimizing risk.

Xampla Ltd is a cleantech company based in Cambridge, United Kingdom, that specializes in developing plant protein-based materials as sustainable alternatives to traditional plastics and microplastics. Founded in 2018, Xampla produces a variety of products, including microcapsules, films, coatings, and beads, which are designed for use in sectors such as food, cosmetics, household products, animal feed, packaging, and medical applications. All materials are biodegradable and biocompatible, made without synthetic ingredients, allowing clients to create environmentally friendly products that minimize pollution.

ZeroAvia, Inc. is a company focused on developing zero-emission aircraft for commercial short-haul flights. Established in 2017 and headquartered in Hollister, California, with an office in Cranfield, United Kingdom, ZeroAvia specializes in hydrogen-electric propulsion systems. These systems are designed to eliminate aviation emissions while ensuring operational efficiency. The company aims to provide scalable technologies that can retrofit existing aircraft, thereby facilitating a transition to sustainable aviation. By collaborating with various stakeholders, ZeroAvia seeks to revolutionize the aviation industry through cleaner and more efficient flight options. Their powertrain utilizes a hydrogen fuel-cell system in limited-seat fixed-wing aircraft, which not only reduces emissions but also allows for the use of existing infrastructure, thus simplifying regulatory challenges and lowering both fuel and maintenance costs for aviation companies.

Refeyn Ltd, founded in 2018 and based in Oxford, United Kingdom, specializes in mass photometry technology for the analysis of biomolecules. The company's flagship product, Refeyn One, employs single molecule light scattering to detect, image, and accurately determine the mass of biomolecules in solution. This innovative optical technology allows researchers to measure the mass of individual molecules in their native state without the necessity for labels, providing both quality-control instruments and advanced research tools. Refeyn's offerings enable scientists to conduct mass measurements across a range of biologically relevant concentrations, enhancing the capabilities of biomolecular analysis.

Federation Bio Inc. is focused on developing microbial therapeutics aimed at curing various diseases through the human microbiome. The company utilizes platforms that harness naturally occurring or engineered bacteria, along with a supportive community of bacteria, to promote engraftment and achieve lasting therapeutic responses. Its research encompasses a broad spectrum of conditions, including secondary hyperoxaluria, metabolic disorders, immune diseases, cholestatic diseases, and cancer. Founded in 2018 and headquartered in South San Francisco, California, Federation Bio was previously known as Comet Medicine Inc. before rebranding in April 2019.

Carmot Therapeutics, Inc. is a clinical-stage biotechnology company based in Berkeley, California, with an additional office in San Francisco. Founded in 2008, the company focuses on discovering and developing therapies for metabolic diseases, including obesity and diabetes. Carmot employs a proprietary drug discovery approach known as Chemotype Evolution, which enables the exploration of novel chemical and biological frontiers. The company is advancing a portfolio of clinical-stage drug candidates, including CT-388, a once-weekly injectable dual GLP-1/GIP receptor agonist; CT-996, a once-daily oral GLP-1 receptor agonist; and CT-868, a once-daily injectable dual GLP-1/GIP receptor agonist for treating type 1 diabetes in patients with overweight or obesity. These innovative therapies aim to enhance glucose clearance and promote weight loss, addressing the fundamental causes of metabolic diseases.

Brightseed, Inc. is a biotechnology company based in San Francisco, California, that specializes in the discovery of bioactive compounds in plants to enhance human health. Utilizing its advanced Forager platform, which employs artificial intelligence and machine learning algorithms, Brightseed accelerates the identification and validation of clinically beneficial molecules. This innovative approach enables the company to uncover connections between natural compounds and health outcomes, revealing the potential of bioactives that have previously remained uncharted. By integrating these discoveries back into the food supply chain, Brightseed collaborates with various companies across the consumer health continuum to develop science-backed health solutions aimed at managing chronic diseases and improving overall quality of life. Founded in 2017, Brightseed is committed to exploring the untapped resources of the plant kingdom to address pressing health challenges.

Curio is a platform that allows individuals to stay informed by listening to hand-picked human-narrated news and articles from reliable publications, plus original shows and podcasts. Curio allows users to listen to the best articles from The Atlantic, The Wall Street Journal, The Financial Times, WIRED, The Economist, The Washington Post, Bloomberg, Aeon, and many other publications.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Atomo Coffee Inc, founded in 2019 and headquartered in Seattle, Washington, specializes in the production of molecular coffee. The company has developed a unique process that reverse-engineers the coffee bean, allowing it to create a smooth cup of coffee using naturally derived ingredients. This innovative approach not only enhances the flavor profile but also offers a more sustainable alternative to traditional coffee production methods.

Docket, Inc. is a company that specializes in providing an online platform tailored for creating meeting agendas. Founded in 2018 and based in Indianapolis, Indiana, the platform enables users to collaborate on agenda creation, document decisions, and track action items effectively. This meeting-focused workspace aims to enhance productivity and organization during meetings, facilitating better communication and follow-up among participants.

Perfect Day produces dairy proteins that are nutritionally identical to proteins from cow’s milk. Perfect Day is pioneering a whole new era in animal-free dairy products. One the delivers all of the taste, texture, and nutrition of dairy with none of the food safety, environmental, or animal welfare downsides. The company's animal-free approach, based on the safe and proven techniques that give the consumers beer or vegetarian rennet also provides consumers and food manufacturers with the same product they all know and love - through a more sustainable and compassionate process. It was founded in 2014 and is headquartered in Emeryville, California.

Loam Bio is a developer of microbial carbon sequestration technology for soil carbon restoration. Crops can be inoculated with symbiotic microorganisms that live in a mutualistic relationship with crops and build organic carbon in the soil, allowing farmers to improve the host plant's fertility and disease resistance while also assisting the soil around the plant's roots to store carbon more effectively, resulting in proper quality soil for future planting. Loam Bio was established in 2019 by Guy Hudson.

Ansa Biotechnologies is manufactured via a chemical method that has remained essentially unchanged for 35 years and has approached a plateau. Ansa Biotechnologies is developing a novel DNA synthesis technology based on enzymes that will be more fast, accurate, and clean than existing methods. The technique promises to dramatically accelerate innovation in biological research and engineering.

Surrozen, Inc. is a clinical-stage biopharmaceutical company based in South San Francisco, California, focused on developing targeted regenerative antibodies to repair damaged tissues and improve organ function. The company utilizes antibody platforms that act as Wnt and R-spondin mimetics to stimulate tissue regeneration in a variety of organs. Its key programs include SZN-043, which aims to promote hepatocyte regeneration in liver diseases, and SZN-1326, designed to repair diseased epithelial tissue for patients with inflammatory bowel disease. Surrozen's research targets several disease areas, including conditions affecting the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system, by engaging the body’s natural biological repair mechanisms. The company was incorporated in 2015 and continues to advance its innovative therapeutic approaches.